Valeo Pharma

What Valeo Pharma does

Valeo Farma S.p.A. is an Italian B2B contract manufacturer of dietary supplements and phytotherapeutic products, operating from a single facility in the Termini Imerese industrial zone (province of Palermo, Sicily). Founded circa 2014 and founder-owned under Vincenzo Licalsi, the company produces on behalf of nutraceutical brands and pharmaceutical companies seeking private label and toll manufacturing without investing in their own production infrastructure. Core manufacturing capabilities span four dosage formats — tablets (simple, orosoluble, chewable, sublingual, soluble, coated), capsules (sizes 3, 1, O, OO; vegetable and gelatin), sachets (fluid bed and wet phase granulation), and liquid forms (syrups, hydroalcoholic extracts, bud extracts, essential oils in containers from 20 mL to 1 L). In-house certified laboratories perform quality control including granulometry, chemical analysis, content uniformity, organoleptic checks, weight uniformity, thickness, and crushability testing. The technology platform relies on cGMP FDA-aligned procedures, fluid bed granulation equipment, and a supply chain of over 500 certified raw materials (supplements, antioxidants, amino acids, vitamins, minerals, glycerinated macerates, standardized dry extracts). Production scale metrics indicate daily semi-finished throughput of ~1.5M tablets/capsules, 200k sachets, and 15,000 L of liquid mixtures, with finished output of 50k blister-packed or jar-packed tablets/capsules per day.

The business model is quote-based contract manufacturing: revenue is generated through project-by-project manufacturing fees tied to formulation complexity and volume, supplemented by professional services revenue from custom formulation R&D and turnkey packaging/logistics. Pricing is not publicly disclosed and each engagement involves bespoke formulation, primary and secondary packaging, graphic design, and courier-based logistics. The go-to-market is enterprise field sales targeting brands and companies seeking private label production, supported by a corporate website, LinkedIn, Facebook presence, downloadable brochures, and direct contact forms. The regulatory and quality stack — FDA registration, ISO 9001:2023, ISO 14001, ISO 22000:18, GMP 2023, IFS Food v8, GDPR compliance, Rating di Legalità (2 stars), and D.Lgs. 231/2001 organizational model — anchors credibility for regulated-market B2B clients, with the FDA registration explicitly enabling US-bound production. An ongoing research partnership with the University of Palermo supports custom formulation development grounded in ethnopharmacology and phytocomplex mechanisms of action. An active capital project, "Investimenti sostenibili 4.0" (CUP C65H23001450005), is expanding production capacity through digital transformation and integration of powder recovery/reuse systems. Customer concentration, revenue, and headcount growth metrics are not disclosed in available source material.

Name

Valeo Pharma

Legal name

Valeo Farma S.p.A.

Website

https://valeofarma.it

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Valeo Farma S.p.A. is an Italian B2B contract manufacturer that produces cGMP FDA-certified dietary supplements and phytotherapeutic products — tablets, capsules, sachets, and liquids — for nutraceutical brands and pharmaceutical companies seeking private label manufacturing.

Ownership category

akta.pro rank

Product category

Contract Dietary Supplement Manufacturing

SIC

Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)

akta.pro primary industry

Medicinal Plant Farming (Botanical/Pharmaceutical Crops) (AFAGAGAE)

Keywords

• Contract manufacturing
• Dietary supplements
• Phytotherapeutic products
• Private label production
• Nutraceutical manufacturing

Headquarters

HQ city

Termini Imerese

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Production of dietary supplements and phytotherapeutic products on behalf of third-party brands and companies. Revenue generated through manufacturing fees based on production volumes and complexity of formulations. Includes primary and secondary packaging services.
2. Custom Formulation Development: Bespoke formulation development services for clients with product ideas but no final formulation. Includes experimental phase on small batches to understand dynamics and improvements needed.
3. Packaging and Logistics Services: Turnkey project services including production, packaging, graphic design, and logistics using trusted couriers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Valeo Farma is a B2B contract manufacturer that produces dietary supplements and phytotherapeutic products under cGMP FDA Good Manufacturing Practice standards. The company manufactures tablets, capsules, sachets, and liquid/syrup dosage forms using over 500 certified raw materials, and offers custom formulation development, primary/secondary packaging, graphic design, and logistics services as turnkey projects for nutraceutical brands and pharmaceutical companies.

Product overview

Valeo Farma is a contract manufacturing company specializing in dietary supplements (integratori alimentari) and phytotherapeutic products (prodotti fitoterapici). The company operates as a single unified offering with integrated services spanning from custom formulation development to final packaging and logistics. Core products include tablets (compresse), capsules, sachets (bustine), and liquid syrups, supported by GMP/FDA-certified manufacturing facilities. The product portfolio is organized around pharmaceutical manufacturing with related services including custom formulation R&D, primary/secondary packaging, graphic design, and logistics coordination.

Differentiator

Problem solved

Functional benefit

Products and services

• Tablet (Compresse) Manufacturing

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• University of Palermo (Università degli Studi di Palermo)coreStrategic or Co-development PartnerValeo Farma maintains continuous contact with the University of Palermo for important collaborations and insights for developing new technologies and research on mechanisms of action of phytocomplexes and individual active principles based on ethnopharmacology studies. This partnership supports the formulation of high-tech products that incorporate new scientific knowledge in phytotherapy.

Scale indicators8 records

Recent moves7 records

Expansion highlights4 records

Market position

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/FarmaValeo

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Valeo Pharma